University of Illinois at Chicago
1747 W. Roosevelt Road, Room 160
Chicago, Illinois 60608
HALP Clinic /ADHD Research Center
900 Skokie Blvd, Suite 13
Northbrook, Il. 60062
Appointments: (312) 996 4331
Voice Mail: (847) 412-0098
Fax: (847) 412-0910
Office Phone: (312) 996-5797
Office Fax: (847) 412 0910
Allison Zoronski, (312) 996 4331
Stein, M.A., Blondis, T.A., Schnitzler, E.R., O'Brien, T., Fishkin, J., Blackwell, B, Szumowski, E., & Roizen, N. (1996). Methylphenidate dosing: Twice daily versus three times daily. Pediatric s, 98,748-756.
Stein, M.A., Krasowski, M., Leventhal, B.L., Phillips, W., & Bender, B.G (1996). Behavioral and cognitive effects of methylxanthines: A meta-analysis of theophylline and caffeine. Archives of Pediatric and Adolescent Medicine, 150, 284-288.
Cook, E.H., Stein, M.A., Krasowski, MD, Cox, N.J., Olkon, D.M., Kieffer,J.E., & Leventhal, B.L. (1995) Association of Attention-Deficit Disorder and the Dopamine Transporter Gene. American Journal of Human Genetics, 56, 993-998.
Stein, M.A. (1999) Unraveling sleep problems in treated and untreated children with ADHD. Journal of Child and Adolescent Psychopharmacology , 9,157-158
Accardo P., Blondis, T., Whitman,B. & Stein, M. (1999) Attention Deficits and Hyperactivity in Children and Adults (2nd Ed), Marcel Dekker: New York , 760pp.
Stein, M.A., Mendelsohn, J., Obermeyer,W.H., & Benca, R. Sleep and Behavior Problems in School-Age Children. Pediatric s (electronic version), 2001.
Stein, M.A. & Weiss, R.E. Thyroid Function Tests and Neurocognitive Functioning in Children Referred for ADHD. Psychoneuroendocrinology (2003), 28, 3,304-16.
Stein, M.A., Sarampote, C.S., Waldman,I.D., Robb, A.S., Conlon,C., Pearl, P.L., Black,D., Seymour, K & Newcorn,J.H. (2003) A Dose-Response Study of OROS Methylphenidate in Children with Attention Deficit Hyperactivity Disorder. Pediatrics, 112; e404-413.
Stein, M.A., Waldman, ID., Sarampote C.S., Seymour, K, Robb A., Kim, S.J., & Cook, E.H. (2005) Dopamine Transporter Genotype and Methylphenidate Dose-Response in Children with ADHD. Neuropsychopharmacology .30, 1374-1382.
Wilens T, McBurnett K, Stein M, Lerner M, Spencer T, Wolraich M, ADHD treatment with once-daily OROS methylphenidate: Final results from a long term open label study. Journal of the American Academy of Child and Adolescent Psychiatry (2005), 44, (10), 1015-1023
McGough, J.J., McBurntett, K., Buckstein, O., Wilens, T,Greenhill, L., Lerner, M & Stein, M. Once-daily OROS Methylphenidate is Safe and Well Tolerated in Adolescents with Attention Deficit/Hyperactivity Disorder (2006). Journal of Child and Adolescent Psychopharmacology
Yang, S.J., Shin, D.W, Hoh, K.S. & Stein, M. Cortisol is inversely correlated with aggression for those boys with ADHD who retain their reactivity to stress. (2007) Psychiatric Research (2007)
Stein M, McGough J. The Pharmacogenetic Era: Promise for Personalizing ADHD Therapy. Child Adolesc Psychiatr Clin N Am. 2008; 17 (8), 475-490.
IJR Faculty Member
Mark A. Stein PhD
Professor, Dept of Psychiatry and Pediatrics
Director of HALP and EADHD Clinical Research Program
Dr. Stein is a clinical psychologist, researcher, Professor, and Director of the ADHD Clinical Research Program. Dr. Stein directs the Hyperactivity, Attention, and Learning Problems Clinic at IJR and Northbrook, and the Adult ADHD Clinic at the Neuropsychiatric Institute. He has specialized in ADHD in al age groups for more than 25 years.
Dr. Stein has written more than 100 articles, co-edited the text book Attention Deficits and Hyperactivity in Children and Adults (Marcel Dekker, 2000), and has participated in numerous clinical trials of ADHD medications.
His research has emphasized diagnosis of ADHD, genetics, thyroid, and psychopharmacology. Current research is on pharmacogenetics, dose response effects of medication, predicting response to methylphenidate and atomoxetine, and sleep problems.
- Personalizing ADHD treatment, Adult ADHD, Sleep and tolerability of ADHD Medications
- Methylphenidate-Atomoxetine Crossover Study (MACRO)
- Sleep and tolerability of dexmethylphenidate versus mixed amphetamine salts
- Camp STAR (Summer Treatment for ADHD and Related Problems)